Company
About Us
Leadership
Contact
Science
PAM Pathway
Gedatolisib
Scientific Publications
Medicines
REVTORPYK®
Patient Advocacy
Pipeline
Our Pipeline
Clinical Trials
Expanded Access Program
Investors
Corporate Overview
Press Releases
Events & Presentations
Stock Information
Stock Quote & Chart
Historic Price Lookup
SEC Filings
Corporate Governance
Documents & Charters
Mangement Team
Board of Directors
Committee Composition
Analyst Coverage
IR Resources
Email Alerts
Contact IR
Careers
Our Culture
Job Openings
Expanded Access Program
Select Page
Company
About Us
Leadership
Contact
Science
PAM Pathway
Gedatolisib
Scientific Publications
Medicines
REVTORPYK®
Patient Advocacy
Pipeline
Our Pipeline
Clinical Trials
Expanded Access Program
Investors
Corporate Overview
Press Releases
Events & Presentations
Stock Information
Stock Quote & Chart
Historic Price Lookup
SEC Filings
Corporate Governance
Documents & Charters
Mangement Team
Board of Directors
Committee Composition
Analyst Coverage
IR Resources
Email Alerts
Contact IR
Careers
Our Culture
Job Openings
Expanded Access Program
Medicines
Product Website
Prescribing Information
Patient Information
We’re proud to announce that REVTORPYK has been approved by the U.S. Food & Drug Administration!
Read Our Press Release
Visit Product Website
Full Prescribing Information
© 2026 Celcuity Inc. All rights reserved. REVTORPYK and its logo are trademarks of Celcuity Inc. US-G1B-26-0242